Biogen Inc Catalyst Calendar

Proactively evaluate Biogen Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Biogen Inc Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 260+ results. Subscribe to unlock more.
02 Oct 2019 GDCTXXXX Lorem Lorem Lorem XXXX Planned Lorem
21 Sep 2019 Phase I Trial Initiation Biogen Inc; Ionis Pharmaceuticals Inc BIIB; IONS ION-859 Central Nervous System Parkinson's Disease Clinical Trial Registry
01 Sep 2019 Phase IV Trial Initiation Biogen Inc; Cedars-Sinai Medical Center; University of Southern California BIIB natalizumab Central Nervous System Multiple Sclerosis; Relapsing Remitting Multiple Sclerosis (RRMS) Clinical Trial Registry
31 Aug 2019 Phase II Trial Initiation Biogen Inc BIIB glyburide Central Nervous System Traumatic Brain Injury Clinical Trial Registry
Catalyst Calendar

Feature

Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.

Benefit

Access:

  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)

Value

Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer